ANTENATAL INVESTIGATION OF DUCTUS VENOSUS VELOCITY AS A METHOD OF DETECTING THE FETAL HEART FAILURE, CAUSED BY PARVOVIRUS B19 INFECTION

Authors

  • N. P. Bondarenko
  • A. V. Aksonova BOGOMOLETS NATIONAL MEDICAL UNIVERSITY

DOI:

https://doi.org/10.11603/ijmmr.2413-6077.2017.2.8396

Keywords:

ductus venosus (DV), heart failure, parvovirus B19 infection, peak systolic blood flow velocity, fetal echocardiography (EchoCG).

Abstract

Background. The article describes the methods and results of investigation of blood flow velocity waveforms in fetal ductus venosus (DV). These studies are used to visualize the degree of fetal heart failure and determine its further clinical course.

Objective. The study was aimed to predict the development of heart failure in the fetuses that were infected with parvovirus B19 infection during 11-14 gestation weeks by measuring the Doppler parameters of blood flow velocity in the DV.

Methods. Our investigation involved 20 pregnant women aged from 18 to 30 years old who were infected with parvovirus B19 infection during the period from 11 to 14 weeks of gestation. The DV was determined by means of color Doppler. Fetal echocardiography (EchoCG) was performed by means of the ultrasound scanner Philips HD IIXE device (USA) using a transabdominal convex probe with the frequency of 3.5 MHz, operating in a CDC mode and the frequency filter at 100 Hz. The A-wave directivity evaluation in the DV was investigated according to the Guideline Principles of the Fetal Medicine Foundation (www.fetalmedicine.com). Statistical processing of data was carried out using the package of applied programs Microsoft Office Excel 2016 and Statistica 6, Stata 12.

Results. In 16 of 20 (80%) fetuses we did not observe any absent or reversed A-wave flow in the DV during atrial contraction as well as any fetal echocardiographic pathological signs. In 2 (10%) cases a reversed A-wave flow in the DV in a combination with EchoCG-signs of overload of left side of heart, resulting in enlargement (dilatation) of left atrium and left ventricle were detected. In 2 (10%) cases the presence of a reversed A-wave flow in the DV and EchoCG-signs of fetal heart failure (reduction of cardiac output, significant dilatation of left ventricle) were evidenced.

The results of the study confirm that with the expansion of fetal nuchal translucency thickness, the systolic blood flow velocity in the DV increases with the correlation coefficient r=0.594, which proves a linear dependence between these two ultrasonography parameters.

Conclusions. The linear correlation between the presence of a reversed A-wave blood flow velocity in the DV and the overload of left side of fetal heart, development of heart failure (20% of the total number of examined women) were proved.

Author Biography

N. P. Bondarenko

BOGOMOLETS NATIONAL MEDICAL UNIVERSITY 

References

Arabzadeh S. Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran. Blood Res. 2017;52(1):50–54.

Zavattoni M, Paolucci S, Sarasini A. Diagnostic and prognostic value of molecular and serological investigation of human parvovirus B19 infection during pregnancy. New Microbiol. 2016;39:181–185.

Lamont RF. Parvovirus B19 infection in human pregnancy. BJOG. 2011;18(2):175–186.

Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016;69(4):279–91.

Crane J. Parvovirus B19 Infection in Pregnancy. J Obstet Gynaecol. 2014;36(12):1107–1116.

Verdonschot J. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. European Journal of Heart Failure. 2016;18,1430–1441.

Hichijo A, Morine M. A case of fetal parvovirus B19 myocarditis that caused terminal heart failure. Case Reports in Obstet and Gynecol. 2014:1–4.

Downloads

Published

2017-12-29

How to Cite

Bondarenko, N. P., & Aksonova, A. V. (2017). ANTENATAL INVESTIGATION OF DUCTUS VENOSUS VELOCITY AS A METHOD OF DETECTING THE FETAL HEART FAILURE, CAUSED BY PARVOVIRUS B19 INFECTION. International Journal of Medicine and Medical Research, 3(2), 30–33. https://doi.org/10.11603/ijmmr.2413-6077.2017.2.8396